NCT05453968 - Berotralstat Treatment in Children With Hereditary Angioedema | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 25, 2022

Primary Completion Date

September 11, 2024

Study Completion Date

February 28, 2027

Conditions

Hereditary AngioedemaPediatric

Interventions

DRUG

Berotralstat

Administered orally once daily at a weight-based dose in up to 4 cohorts

Trial Locations (15)

Investigative Site #1, Vienna

Investigative Site #1, Ottawa

Investigative Site #3, Grenoble

Investigative Site #2, Marseille

Investigative Site #1, Paris

Investigative Site #1, Berlin

Investigative Site #2, Frankfurt

Investigative Site #2, Haifa

Investigative Site #1, Tel Aviv

Investigative Site #1, Padua

Investigative Site #1, Krakow

Investigative Site #1, Sângeorgiu de Mureş

Investigative Site #1, Madrid

Investigative Site #2, Málaga

Investigative Site #1, Bristol